Fluminense says goalkeeper Fabio has broken the record for most matches played with his 1,391st appearance to surpass England's Peter Shilton. Fabio achieved this milestone on Tuesday during Fluminens ...

Cadillac has countdown clocks in all its offices marking time until its debut in Formula 1 next season. Team principal Graeme Lowdon tells The Associated Press he's been taking lessons ...

Target CEO Brian Cornell plans to step down Feb. 1. He helped reenergize the company but has struggled to turn around weak sales in a more competitive retail landscape. Minneapolis-based ...

(NASDAQ: REAX, “Real”), a leading real estate technology platform redefining the industry through innovation and culture, today released results from its July 2025 Agent Survey. The data shows a ...

Wisconsin wants to start a new string of bowl appearances after allowing its streak of 22 straight winning season to end with a late tailspin a year ago. A demanding ...

EliseAI, the AI company automating complex healthcare and housing systems, today announced its Series E raise of $250 million. The round was led by Andreessen Horowitz (a16z), with participation from ...

An unnamed Clinton County man sustained non-life threatening injuries after leading police on a chase and shootout Tuesday ...

Chewy, Inc. (NYSE: CHWY) (“Chewy”), a trusted destination for pet parents and partners everywhere, announced today that it will report fiscal second quarter 2025 financial results before the market ...

The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of $1.50 per share. The container shipping company ...

NATO defense chiefs are holding a virtual meeting to discuss security guarantees for Ukraine as part of efforts to end Russia's war on its neighbor. Italian Admiral Giuseppe Cavo Dragone ...

In its correspondence, the FDA confirmed that Rocket satisfactorily addressed issues outlined in the clinical hold. The FDA authorized the pivotal study to resume first with a recalibrated dose of 3.8 ...

Novocure (NASDAQ: NVCR) today announced it submitted a premarket approval (PMA) application to the U.S. Food and Drug Administration (FDA) for Tumor Treating Fields (TTFields) therapy for the ...